Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 47,613 | 36,951 | 21,716 | 23,597 | 22,032 |
| Operating Income | -47,613 | -36,951 | -21,716 | -23,597 | -22,032 |
| Interest Expense | 3,381 | 0 | 0 | 0 | 0 |
| Other Income | 467 | -250 | 207 | 349 | 726 |
| Pre-tax Income | -50,527 | -37,201 | -21,509 | -23,248 | -21,306 |
| Income Tax | 5 | 2 | -3 | 3 | 4 |
| Net Income Continuous | -50,532 | -37,203 | -21,506 | -23,251 | -21,310 |
| Net Income | $-50,532 | $-37,203 | $-21,506 | $-23,251 | $-21,310 |
| EPS Basic Total Ops | -1.68 | -1.44 | -0.86 | -0.93 | -0.86 |
| EPS Basic Continuous Ops | -1.68 | -1.44 | -0.86 | -0.93 | -0.86 |
| EPS Diluted Total Ops | -1.68 | -1.44 | -0.86 | -0.93 | -0.86 |
| EPS Diluted Continuous Ops | -1.68 | -1.44 | -0.86 | -0.93 | -0.86 |
| EBITDA(a) | $-47,422 | $-36,786 | $-21,561 | $-23,450 | $-21,876 |